Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/98577
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Fabritz, Larissa | - |
dc.contributor.author | Hoogendijk, Mark G. | - |
dc.contributor.author | Scicluna, Brendon P. | - |
dc.contributor.author | Amersfoorth, Shirley C.M. van | - |
dc.contributor.author | Fortmueller, Lisa | - |
dc.contributor.author | Wolf, Susanne | - |
dc.contributor.author | Laakmann, Sandra | - |
dc.contributor.author | Kreienkamp, Nina | - |
dc.contributor.author | Piccini, Ilaria | - |
dc.contributor.author | Breithardt, Günter | - |
dc.contributor.author | Ruiz Noppinger, Patricia | - |
dc.contributor.author | Witt, Henning | - |
dc.contributor.author | Ebnet, Klaus | - |
dc.contributor.author | Wichter, Thomas | - |
dc.contributor.author | Levkau, Bodo | - |
dc.contributor.author | Franke, Werner W. | - |
dc.contributor.author | Pieperhoff, Sebastian | - |
dc.contributor.author | Bakker, Jacques M. T. de | - |
dc.contributor.author | Coronel, Ruben | - |
dc.contributor.author | Kirchhof, Paulus | - |
dc.date.accessioned | 2022-06-30T10:24:46Z | - |
dc.date.available | 2022-06-30T10:24:46Z | - |
dc.date.issued | 2011 | - |
dc.identifier.citation | Fabritz, L., Hoogendijk, M. G., Scicluna, B. P., Van Amersfoorth, S. C., Fortmueller, L., Wolf, S., ... & Kirchhof, P. (2011). Load-reducing therapy prevents development of arrhythmogenic right ventricular cardiomyopathy in plakoglobin-deficient mice. Journal of the American College of Cardiology, 57(6), 740-750. | en_GB |
dc.identifier.uri | https://www.um.edu.mt/library/oar/handle/123456789/98577 | - |
dc.description.abstract | Objectives: We used a murine model of arrhythmogenic right ventricular cardiomyopathy (ARVC) to test whether reducing ventricular load prevents or slows development of this cardiomyopathy. | en_GB |
dc.description.abstract | Background: At present, no therapy exists to slow progression of ARVC. Genetically conferred dysfunction of the mechanical cell-cell connections, often associated with reduced expression of plakoglobin, is thought to cause ARVC. | en_GB |
dc.description.abstract | Methods: Littermate pairs of heterozygous plakoglobin-deficient mice (plako(+/-)) and wild-type (WT) littermates underwent 7 weeks of endurance training (daily swimming). Mice were randomized to blinded load-reducing therapy (furosemide and nitrates) or placebo. | en_GB |
dc.description.abstract | Results: Therapy prevented training-induced right ventricular (RV) enlargement in plako(+/-) mice (RV volume: untreated plako(+/-) 136 ± 5 μl; treated plako(+/-) 78 ± 5 μl; WT 81 ± 5 μl; p < 0.01 for untreated vs. WT and untreated vs. treated; mean ± SEM). In isolated, Langendorff-perfused hearts, ventricular tachycardias (VTs) were more often induced in untreated plako(+/-) hearts (15 of 25), than in treated plako(+/-) hearts (5 of 19) or in WT hearts (6 of 21, both p < 0.05). Epicardial mapping of the RV identified macro-re-entry as the mechanism of ventricular tachycardia. The RV longitudinal conduction velocity was reduced in untreated but not in treated plako(+/-) mice (p < 0.01 for untreated vs. WT and untreated vs. treated). Myocardial concentration of phosphorylated connexin43 was lower in plako(+/-) hearts with VTs compared with hearts without VTs and was reduced in untreated plako(+/-) compared with WT (both p < 0.05). Plako(+/-) hearts showed reduced myocardial plakoglobin concentration, whereas β-catenin and N-cadherin concentration was not changed. | en_GB |
dc.description.abstract | Conclusions: Load-reducing therapy prevents training-induced development of ARVC in plako(+/-) mice. | en_GB |
dc.language.iso | en | en_GB |
dc.publisher | Elsevier Inc. | en_GB |
dc.rights | info:eu-repo/semantics/restrictedAccess | en_GB |
dc.subject | Heart -- Diseases -- Patients | en_GB |
dc.subject | Heart -- Hypertrophy | en_GB |
dc.subject | Dysplasia | en_GB |
dc.subject | Connexin 43 | en_GB |
dc.subject | Diuretics | en_GB |
dc.subject | Furosemide | en_GB |
dc.title | Load-reducing therapy prevents development of arrhythmogenic right ventricular cardiomyopathy in plakoglobin-deficient mice | en_GB |
dc.type | article | en_GB |
dc.rights.holder | The copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder | en_GB |
dc.description.reviewed | peer-reviewed | en_GB |
dc.identifier.doi | 10.1016/j.jacc.2010.09.046 | - |
dc.publication.title | Journal of the American College of Cardiology | en_GB |
Appears in Collections: | Scholarly Works - FacHScABS |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Load_reducing_therapy_prevents_development_of_arrhythmogenic_right_ventricular_cardiomyopathy_in_plakoglobin_deficient_mice.pdf Restricted Access | 1.62 MB | Adobe PDF | View/Open Request a copy |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.